10-Q: Helix Acquisition Corp. II Reports Net Income of $2.2 Million for Quarter Ended June 30, 2024

Sentiment:

Quarterly Report


Helix Acquisition Corp. II reported a net income of $2.2 million for the quarter ended June 30, 2024, primarily driven by interest earned on marketable securities held in trust.

Capital raiseThe company completed an IPO of 18,400,000 Class A ordinary shares at $10.00 per share, raising $184,000,000.The company also sold 509,000 private placement shares at $10.00 per share, raising $5,090,000.The company may need to raise additional capital to complete a business combination.

Summary

  • Helix Acquisition Corp. II, a special purpose acquisition company, reported a net income of $2,212,536 for the three months ended June 30, 2024.
  • This net income was primarily due to $2,442,279 in interest earned on marketable securities held in the Trust Account.
  • The company incurred general and administrative expenses of $152,343 and share-based compensation expenses of $77,400 during the quarter.
  • For the six months ended June 30, 2024, the company's net income was $3,312,978, with interest income of $3,648,794, offset by $219,044 in general and administrative expenses and $116,772 in share-based compensation expenses.
  • As of June 30, 2024, the company held $187,648,794 in marketable securities in its Trust Account.
  • The company's total assets were $189,874,488, and total liabilities were $5,599,141.
  • The company has until February 13, 2026, to complete a business combination.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the company has successfully completed its IPO and is generating income from its trust account. However, the company is still in the early stages and faces the risk of not completing a business combination.

Positives

  • The company generated significant net income due to interest earned on its Trust Account.
  • The company successfully completed its IPO and private placement, raising substantial capital.
  • The company has a substantial amount of assets held in its Trust Account, which can be used for a business combination.

Negatives

  • The company has not yet commenced any operations and is incurring administrative and share-based compensation expenses.
  • The company has a limited time frame to complete a business combination.

Risks

  • The company is a blank check company and has not yet identified a target for a business combination.
  • The company may not be able to complete a business combination within the required timeframe.
  • The company may need to obtain additional financing to complete a business combination.
  • The company's expenses may exceed its available funds if a business combination is not completed.

Future Outlook

The company intends to use the funds held in the Trust Account to complete a business combination within 24 months of the IPO date. The company may need to obtain additional financing to complete the business combination.

Management Comments

  • The company's management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Shares.
  • The company anticipates structuring the initial Business Combination so that the post transaction company in which the Public Shareholders own shares will own or acquire 100% of the equity interests or assets of the target business or businesses.

Industry Context

This is a typical report for a special purpose acquisition company (SPAC) that has recently completed its IPO. The company is focused on identifying a target in the healthcare or healthcare-related industries. The financial results are primarily driven by interest income on the funds held in trust, as the company has not yet commenced operations.

Comparison to Industry Standards

  • The financial performance of Helix Acquisition Corp. II is typical for a SPAC in its early stages, with the majority of its income derived from interest on its trust account.
  • Comparable companies include other healthcare-focused SPACs such as CM Life Sciences and Health Assurance Acquisition Corp, which also report similar financial profiles prior to a business combination.
  • The company's trust account size of $187.6 million is within the typical range for SPACs of this size.
  • The 24-month timeline to complete a business combination is standard for SPACs.

Related Party Transactions

  • The company has an agreement to pay the Sponsor $6,458 per month for office space, utilities, and administrative support services.
  • The Sponsor purchased 509,000 private placement shares for $5,090,000.
  • The company issued an unsecured promissory note to the Sponsor for up to $300,000, which was repaid.
  • The Sponsor or its affiliates may provide working capital loans to the company.

Stakeholder Impact

  • Shareholders will benefit if the company successfully completes a business combination.
  • Employees of the target company will be impacted by the business combination.
  • The company's suppliers and creditors will be impacted by the business combination.

Next Steps

  • The company will continue to seek a target company for a business combination.
  • The company will conduct due diligence on potential target companies.
  • The company will negotiate and complete a business combination within the 24-month timeframe.

Key Dates

DateDescription
June 15, 2021Company incorporated as a Cayman Islands exempted company.
June 19, 2021Sponsor paid $25,000 for 2,875,000 Class B ordinary shares.
November 29, 2023Sponsor transferred 30,000 Founder Shares to each of the independent directors and advisor.
February 1, 2024Share capitalization of 1,437,500 Class B ordinary shares.
February 8, 2024Share capitalization of 287,500 Class B ordinary shares and effective date of the administrative services agreement.
February 13, 2024Company consummated its Initial Public Offering (IPO) and sale of private placement shares.
June 30, 2024End of the reporting period for the quarterly report.
August 14, 2024Date of the quarterly report filing.

Keywords

SPAC, Business Combination, IPO, Trust Account, Healthcare, Acquisition, Special Purpose Acquisition Company, Private Placement, Marketable Securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.